We are live on ! Find out more
IMA

ImageneBio Inc
IMA

52 hedge funds and large institutions have $205M invested in ImageneBio Inc in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

171% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 7

137% more capital invested

Capital invested by funds: $86.2M → $205M (+$118M)

33% more funds holding

Funds holding: 39 → 52 (+13)

0.39% more ownership

Funds ownership: 5.74% → 6.13% (+0.39%)

Holders
52
Holders Change
+13
Holders Change %
+33.33%
% of All Funds
0.82%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
17
Increased
19
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.5M
2
ACA
Avoro Capital Advisors
New York
+$9.8M
3
BlackRock
BlackRock
New York
+$5.74M
4
ACP
Acuta Capital Partners
California
+$3.33M
5
CA
CHI Advisors
New York
+$2.76M

Top Sellers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
-$3.2M
2
Citadel Advisors
Citadel Advisors
Florida
-$848K
3
DCM
DAFNA Capital Management
California
-$390K
4
Millennium Management
Millennium Management
New York
-$376K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$137K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$33.3M +$10.5M +146,454 +53%
AVLSA
2
Atlas Venture Life Science Advisors
Massachusetts
$32.9M – – –
O
3
OrbiMed
New York
$20.9M – – –
BI
4
BVF Inc
California
$20.8M – – –
OFM
5
Omega Fund Management
Massachusetts
$14.8M – – –
CA
6
CHI Advisors
New York
$13.9M +$2.76M +38,431 +28%
AG
7
Artal Group
Luxembourg
$12.1M +$1.79M +25,000 +19%
ACA
8
Avoro Capital Advisors
New York
$10.8M +$9.8M +136,667 New
BlackRock
9
BlackRock
New York
$8.31M +$5.74M +80,009 +312%
Vanguard Group
10
Vanguard Group
Pennsylvania
$7.18M +$577K +8,048 +10%
Verition Fund Management
11
Verition Fund Management
Connecticut
$6.96M -$3.2M -44,569 -34%
ACP
12
Acuta Capital Partners
California
$3.66M +$3.33M +46,500 New
LCM
13
Laurion Capital Management
New York
$3.4M -$68.3K -953 -2%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$3.06M +$1.34M +18,706 +92%
Adage Capital Partners
15
Adage Capital Partners
Massachusetts
$2.54M +$2.32M +32,325 New
State Street
16
State Street
Massachusetts
$2.52M +$1.94M +26,992 +540%
Barclays
17
Barclays
United Kingdom
$1.33M +$24.9K +347 +2%
Northern Trust
18
Northern Trust
Illinois
$1.16M +$876K +12,213 +476%
BCM
19
Bridgeway Capital Management
Texas
$752K – – –
Ensign Peak Advisors
20
Ensign Peak Advisors
Utah
$592K – – –
Bank of New York Mellon
21
Bank of New York Mellon
New York
$409K +$373K +5,195 New
Charles Schwab
22
Charles Schwab
California
$398K +$290K +4,049 +402%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$389K +$106K +1,473 +43%
FAM
24
Fred Alger Management
New York
$271K +$247K +3,438 New
CIC
25
Cornercap Investment Counsel
Georgia
$252K -$6.6K -92 -3%
1
2 3

IMA Hedge Fund Activity: Q2 2023 in Review

52 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q2 2023, worth a combined $205M — up 137% from $86.2M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new IMA positions and 4 closed out — a net gain of 13 holders — while 19 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $10.5M. The largest seller was Verition Fund Management, cutting an estimated $3.2M.

  • 52 institutional investors held ImageneBio Inc (IMA) as of Q2 2023, up from 39 in Q1 2023.
  • Funds reported $205M of ImageneBio Inc stock for Q2 2023, up 137% quarter-over-quarter.
  • 17 funds opened new ImageneBio Inc positions in Q2 2023 and 4 closed out, a net change of +13 holders.
  • The largest ImageneBio Inc buyer in Q2 2023 was Fidelity Investments, an estimated $10.5M added.
  • The largest ImageneBio Inc seller in Q2 2023 was Verition Fund Management, an estimated $3.2M sold.

Based on aggregated 13F filings for Q2 2023.